APRINOIA Therapeutics Funding: $11M Raised, Series B (2018)
APRINOIA Therapeutics is based in Boston, Massachusetts. It has raised $11M in total funding. Latest round: Series B.
APRINOIA Therapeutics funding overview
APRINOIA Therapeutics is based in Boston, Massachusetts. APRINOIA Therapeutics has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2018. The round record for APRINOIA Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include KTB Network, DCI Partners, ShangPharma Investment Group, TaiAn Technologies, Daiwa Corporate Investment, Kevin KUK Hyun Kyung and 1 others. 7 distinct backers are named across the disclosed rounds.
APRINOIA Therapeutics at a glance
Total raised
$11M
Latest round
Series B
Latest round date
January 2018
Headquarters
Boston, Massachusetts
Notable investors
KTB Network, DCI Partners, ShangPharma Investment Group, TaiAn Technologies, Daiwa Corporate Investment, Kevin KUK Hyun Kyung, Taian Venture Capital
Frequently asked about APRINOIA Therapeutics funding
How much has APRINOIA Therapeutics raised?
APRINOIA Therapeutics has raised $11M in total disclosed funding across the rounds on record.
Who has invested in APRINOIA Therapeutics?
KTB Network, DCI Partners, ShangPharma Investment Group, TaiAn Technologies, Daiwa Corporate Investment, Kevin KUK Hyun Kyung are named among the investors backing APRINOIA Therapeutics.
What was the latest APRINOIA Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2018.
Where is APRINOIA Therapeutics based?
APRINOIA Therapeutics is based in Boston, Massachusetts.
When did APRINOIA Therapeutics last raise?
The last disclosed APRINOIA Therapeutics round closed in January 2018 at Series B.
Totals shown for APRINOIA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
